Development and Evaluation of a Procedure to Identify Possible Gonorrhea Treatment Failure Cases in Illinois

Sex Transm Dis. 2021 Aug 1;48(8S):S14-S19. doi: 10.1097/OLQ.0000000000001453.

Abstract

Background: Cephalosporins are the last effective class of antibiotics to treat gonorrhea infections. In Illinois, gonorrhea cases have increased by 70.9% from 2015 to 2019. Because of the concern of antimicrobial resistance and the increasing number of cases, the Illinois Department of Public Health Sexually Transmitted Diseases Section established a procedure to identify possible gonorrhea treatment failure cases.

Materials and methods: A procedure was developed that identifies patients who have had 2 gonorrhea cases in the last 60 days, and the first case was treated with the Centers for Disease Control and Prevention-recommended treatment. Interview records were faxed to the local health department (LHD) where the patient resides. Descriptive statistics were used to analyze interview record data. A process evaluation was conducted using telephone interviews with LHDs to obtain qualitative feedback on the procedure.

Results: A total of 310 interview records were sent for investigation in 2018 and 2019 with 263 returned. Of those returned, 140 identified reexposure, 104 were unable to be located, 12 refused to be interviewed, 6 had treatment reported incorrectly, and 1 had a possible treatment failure. From telephone interviews with 6 LHDs, 1 question was removed and 2 questions were added to the interview record.

Conclusions: Antibiotic-resistant gonorrhea could occur in Illinois at any time. Monitoring for antibiotic-resistant gonorrhea cases is necessary as gonorrhea morbidity continues to increase. This procedure may prove to be a model for other states.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cephalosporins
  • Gonorrhea* / drug therapy
  • Gonorrhea* / epidemiology
  • Humans
  • Illinois / epidemiology
  • Sexually Transmitted Diseases* / drug therapy
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Cephalosporins